Skip to content
Clinical Trials – home
Verifiedinfo

Centrum Medyczne MBB-MED Marta Błach-Burek

Poland ul. 11 Listopada 11, 32-590 Libiąż, Poland

  • 1 trial recruiting
  • Cardiac failure · Obesity · Type 2 diabetes mellitus
  • Adult patients

About Specializations

Centrum Medyczne MBB-MED Marta Błach-Burek in Libiąż, Poland specialises in clinical trials of conditions such as Cardiac failure, Obesity, Type 2 diabetes mellitus, Atrial fibrillation, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Research

Centrum Medyczne MBB-MED Marta Błach-Burek focuses on cardiovascular diseases. Current studies evaluate atrial fibrillation and heart failure with preserved or mildly reduced ejection fraction in individuals affected by obesity. One trial tests whether the novel anticoagulant milvexian can match apixaban in preventing stroke. A second study examines if weekly NNC0487-0111 reduces cardiovascular death and heart‑failure hospitalisations.

  • Stroke prevention in atrial fibrillation
  • Evaluation of new oral anticoagulants
  • Management of HFpEF/HFmrEF with obesity
  • Assessment of novel heart‑failure therapies

Located in Libiąż, Poland, the site conducts its trials with a dedicated investigator team, contributing to the advancement of cardiovascular care in Europe.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
ul. 11 Listopada 1132-590 LibiążPoland
Recruiting now
1 trial
Conditions studied
4
Partner status
Verified

More sites in LibiążPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Insulin Glargine
  • Sponsor:Novo Nordisk A/S

Atrial fibrillation

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen - Cilag International
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.